Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population
- PMID: 28509689
- DOI: 10.1097/FPC.0000000000000285
Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population
Abstract
Background: Allopurinol is one of the most common causes of severe cutaneous adverse drug reactions (SCARs) including drug reactions with eosinophilia and systemic symptoms (DRESS), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). This study identified the risk factors associated with the development of allopurinol-induced SCARs in a Thai population.
Patients and methods: Eighty-six allopurinol-induced SCARs (i.e. 19 DRESS and 67 SJS/TEN) and 182 allopurinol-tolerant patients were enrolled in the study. The HLA-B*58:01 allele was determined. Clinical and medicinal data were collected.
Results: Results from multivariate analysis showed that only the HLA-B*58:01 and female sex were identified as risk factors of allopurinol-induced SCARs in this Thai population. Patients who carried the HLA-B*58:01 allele were at a higher risk of allopurinol-induced DRESS [odds ratio (OR)=149.2, 95% confidence interval (CI)=24.0-∞, P<1.00×10]. Similar results were observed in allopurinol-induced SJS/TEN (OR=175.0, 95% CI=44.3-690.9, P=1.69×10). The risk of allopurinol-induced SCARs in women was higher than that in men (OR=4.6, 95% CI=1.4-15.6, P=1.44×10). The overall mortality rate of allopurinol-induced SCARs was 11.39% and a higher mortality rate was observed in elderly women.
Conclusion: Among the risk factors identified, the HLA-B*58:01 allele had the greatest impact on the development of both phenotypes of allopurinol-induced SCARs in this studied Thai population. In case HLA-B*58:01 genotyping cannot be accessed, close monitoring of allopurinol usage, especially in elderly women with impaired renal function, is necessary to reduce the mortality rate of these life-threatening SCARs.
Similar articles
-
Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.Pharmacogenet Genomics. 2009 Sep;19(9):704-9. doi: 10.1097/FPC.0b013e328330a3b8. Pharmacogenet Genomics. 2009. PMID: 19696695
-
HLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.Front Pharmacol. 2016 Jul 18;7:186. doi: 10.3389/fphar.2016.00186. eCollection 2016. Front Pharmacol. 2016. PMID: 27486401 Free PMC article.
-
HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population.Br J Dermatol. 2013 Sep;169(3):660-5. doi: 10.1111/bjd.12389. Br J Dermatol. 2013. PMID: 23600531
-
Pharmacogenetics of allopurinol--making an old drug safer.J Clin Pharmacol. 2013 Jul;53(7):675-9. doi: 10.1002/jcph.67. Epub 2013 Feb 4. J Clin Pharmacol. 2013. PMID: 23381951 Review.
-
Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.J Dermatol Sci. 2012 Jun;66(3):190-6. doi: 10.1016/j.jdermsci.2012.04.002. Epub 2012 Apr 11. J Dermatol Sci. 2012. PMID: 22541332 Review.
Cited by
-
A Novel Allele-Specific PCR Protocol for the Detection of the HLA-C*03:02 Allele, a Pharmacogenetic Marker, in Vietnamese Kinh People.Appl Clin Genet. 2021 Feb 9;14:27-35. doi: 10.2147/TACG.S278652. eCollection 2021. Appl Clin Genet. 2021. PMID: 33603436 Free PMC article.
-
Updates in the pathogenesis of SJS/TEN.Allergol Int. 2025 Jul;74(3):361-371. doi: 10.1016/j.alit.2025.05.002. Epub 2025 Jun 4. Allergol Int. 2025. PMID: 40473510 Free PMC article. Review.
-
Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study.CMAJ. 2019 Sep 30;191(39):E1070-E1077. doi: 10.1503/cmaj.190339. CMAJ. 2019. PMID: 31570545 Free PMC article.
-
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine.Pharmaceuticals (Basel). 2021 Oct 25;14(11):1077. doi: 10.3390/ph14111077. Pharmaceuticals (Basel). 2021. PMID: 34832859 Free PMC article. Review.
-
Prevalence of HLA-B*58:01 allele among Malay, Chinese and Indian ethnic patients with gout attending primary care clinics in Malaysia.J Community Genet. 2025 Feb;16(1):37-45. doi: 10.1007/s12687-024-00753-4. Epub 2024 Nov 25. J Community Genet. 2025. PMID: 39586937 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials